ISSN: 0973-7510

E-ISSN: 2581-690X

Yongjun Dong, Lirong Wang , Xingyou Liu and Kun Zhao
1College of Animal Science, Henan Institute of Science and Technology, Xinxiang, Henan, 453003, China.
J Pure Appl Microbiol. 2015;9(2):899-911
© The Author(s). 2015
Received: 25/12/2014 | Accepted: 01/02/2015 | Published: 30/06/2015

Seven strains of bacteria were isolated from clinical cases of swine disease in lungs and trachea. The isolated bacteria was identified as Actinobacillus pleuropneumoniae (APP) serotypes 1 through bacterial cultivated, culture characteristic observation, morphology, biochemical, growth of satellite phenomenon, hemolysis and serotype identification. The antimicrobial susceptibility showed that the isolated A. pleuropneumoniae resistance to penicillins, semisynthetic antibiotics, b-lactam antibiotics, polypeptide antibiotic, polyene antibiotic, coumarin antibiotic, amphenicols antibiotics, b-lactam/b-lactam inhibitor compounds, cephalosporins, aminoglycosides, tetracyclines, fluoroquinolones, macrolides, sulfa drugs, sugar peptide drugs, furan drugs, ethlhydrocupreine; medium sensitive to cephalothin (CF), cefizime (CEX), ciprofloxacin (CIP), norfloxacin (NOR), ofloxacin (OFL); high sensitive to polymyxin B (PB), fosfomycin (FOS), ceftizoxime (CTZ), cefmetazole (CMZ), cefaclor (CEC), cefoperazone/sulbactam (CFP/SU), cefetamet (CTM), cefotaxime (CTX), ceftazidime (CAZ), cefodizine (CDZ), cefurosimc sodium (CXM), cefotaxime/clayulanic acid (CTX/CA), ceftazidime/clavulanic acid (CAZ/CA), cefoxitin (FOX), cefepime (FEP), ceftriazone (CRO),aztreonam (AZT), minocycline. This result showed that A. pleuropneumoniae clinical strains had multi-drug resistance and resistance characteristics, which means that these isolated bacteria was multiple drug resistant strains.


Actinobacillus pleuropneumoniae, Isolation, Identification, Serotype, Antimicrobial resistance, antimicrobial susceptibiligy, Multidrug resistance

Article Metrics

Article View: 0

Share This Article

© The Author(s) 2015. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.